Skip to main content
SpringerLink
Log in

Imaging of Hepatocellular Carcinoma: Current Concepts

  • Chapter
  • First Online:
Multidisciplinary Treatment of Hepatocellular Carcinoma

Part of the book series: Recent Results in Cancer Research ((RECENTCANCER,volume 190))

Abstract

Hepatocellular carcinoma (HCC) is the most common primary hepatic malignancy, and usually develops in the setting of liver cirrhosis. The early diagnosis of HCC is essential as curative treatment (including surgical resection and liver transplantation) improves survival. While screening and surveillance are traditionally performed with ultrasound, reported accuracies of ultrasound vary greatly, and poor sensitivity for small nodules is a uniformly recognized concern. Advances in computed tomography (CT) and magnetic resonance imaging (MRI), including multidetector technology and fast breath hold sequences now allow dynamic multiphasic enhanced imaging of the liver with excellent spatial and temporal resolution, holding much promise for improved HCC detection.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 179.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 229.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 229.00
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

DN:

Dysplastic nodule

DWI:

Diffusion-weighted MR imaging

HCC:

Hepatocellular carcinoma

MDCT:

Multidetector computed tomography

MRI:

Magnetic resonance imaging

RN:

Regenerative nodule

US:

Ultrasound

References

  1. El-Serag HB, Rudolph KL (2007) Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132(7):2557–2576

    PubMed  CAS  Google Scholar 

  2. Parkin DM, Bray F, Ferlay J (2002) Pisani P (2005) Global cancer statistics. CA Cancer J Clin 55(2):74–108

    Google Scholar 

  3. Altekruse SF, McGlynn KA, Reichman ME (2009) Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol 27(9):1485–1491

    PubMed  Google Scholar 

  4. Perz JF, Armstrong GL, Farrington LA, Hutin YJ, Bell BP (2006) The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol 45(4):529–538

    PubMed  Google Scholar 

  5. Ahn J, Flamm SL (2004) Hepatocellular carcinoma. Dis Mon 50(10):556–573

    PubMed  Google Scholar 

  6. Hayashi M, Matsui O, Ueda K, Kawamori Y, Kadoya M, Yoshikawa J, Gabata T, Takashima T, Nonomura A, Nakanuma Y (1999) Correlation between the blood supply and grade of malignancy of hepatocellular nodules associated with liver cirrhosis: evaluation by CT during intraarterial injection of contrast medium. AJR Am J Roentgenol 172(4):969–976

    PubMed  CAS  Google Scholar 

  7. Sakamoto M, Hirohashi S, Shimosato Y (1991) Early stages of multistep hepatocarcinogenesis: adenomatous hyperplasia and early hepatocellular carcinoma. Hum Pathol 22(2):172–178

    PubMed  CAS  Google Scholar 

  8. Kobayashi M, Ikeda K, Hosaka T, Sezaki H, Someya T, Akuta N, Suzuki F, Suzuki Y, Saitoh S, Arase Y, Kumada H (2006) Dysplastic nodules frequently develop into hepatocellular carcinoma in patients with chronic viral hepatitis and cirrhosis. Cancer 106(3):636–647

    PubMed  Google Scholar 

  9. Hayashi M, Matsui O, Ueda K, Kawamori Y, Gabata T, Kadoya M (2002) Progression to hypervascular hepatocellular carcinoma: correlation with intranodular blood supply evaluated with CT during intraarterial injection of contrast material. Radiology 225(1):143–149

    PubMed  Google Scholar 

  10. El-Serag HB, Mason AC (1999) Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 340(10):745–750

    PubMed  CAS  Google Scholar 

  11. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, Montalto F, Ammatuna M, Morabito A, Gennari L (1996) Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334(11):693–699

    PubMed  CAS  Google Scholar 

  12. Wu JT (1990) Serum alpha-fetoprotein and its lectin reactivity in liver diseases: a review. Ann Clin Lab Sci 20(2):98–105

    PubMed  CAS  Google Scholar 

  13. Sherman M, Peltekian KM, Lee C (1995) Screening for hepatocellular carcinoma in chronic carriers of hepatitis B virus: incidence and prevalence of hepatocellular carcinoma in a North American urban population. Hepatology 22(2):432–438

    PubMed  CAS  Google Scholar 

  14. Zhang BH, Yang BH, Tang ZY (2004) Randomized controlled trial of screening for hepatocellular carcinoma. J Cancer Res Clin Oncol 130(7):417–422

    PubMed  Google Scholar 

  15. Bruix J, Sherman M (2005) Management of hepatocellular carcinoma. Hepatology 42(5):1208–1236. doi:10.1002/hep.20933

    PubMed  Google Scholar 

  16. Lencioni R, Pinto F, Armillotta N, Bartolozzi C (1996) Assessment of tumor vascularity in hepatocellular carcinoma: comparison of power Doppler US and color Doppler US. Radiology 201(2):353–358

    PubMed  CAS  Google Scholar 

  17. Gaiani S, Volpe L, Piscaglia F, Bolondi L (2001) Vascularity of liver tumours and recent advances in Doppler ultrasound. J Hepatol 34(3):474–482

    PubMed  CAS  Google Scholar 

  18. Fracanzani AL, Burdick L, Borzio M, Roncalli M, Bonelli N, Borzio F, Maraschi A, Fiorelli G, Fargion S (2001) Contrast-enhanced Doppler ultrasonography in the diagnosis of hepatocellular carcinoma and premalignant lesions in patients with cirrhosis. Hepatology 34(6):1109–1112

    PubMed  CAS  Google Scholar 

  19. Lencioni R, Mascalchi M, Caramella D, Bartolozzi C (1996) Small hepatocellular carcinoma: differentiation from adenomatous hyperplasia with color Doppler US and dynamic Gd-DTPA-enhanced MR imaging. Abdom Imaging 21(1):41–48

    PubMed  CAS  Google Scholar 

  20. Teefey SA, Hildeboldt CC, Dehdashti F, Siegel BA, Peters MG, Heiken JP, Brown JJ, McFarland EG, Middleton WD, Balfe DM, Ritter JH (2003) Detection of primary hepatic malignancy in liver transplant candidates: prospective comparison of CT, MR imaging, US, and PET. Radiology 226(2):533–542

    PubMed  Google Scholar 

  21. Wilson SR, Jang HJ, Kim TK, Iijima H, Kamiyama N, Burns PN (2008) Real-time temporal maximum-intensity-projection imaging of hepatic lesions with contrast-enhanced sonography. AJR Am J Roentgenol 190(3):691–695

    PubMed  Google Scholar 

  22. Ding H, Wang WP, Huang BJ, Wei RX, He NA, Qi Q, Li CL (2005) Imaging of focal liver lesions: low-mechanical-index real-time ultrasonography with SonoVue. J Ultrasound Med 24(3):285–297

    PubMed  Google Scholar 

  23. Tombesi P, Catellani M, Abbasciano V, Sartori S, Tassinari D (2008) Impact of contrast-enhanced ultrasonography in a tertiary clinical practice. J Ultrasound Med 27(6):991–992

    PubMed  Google Scholar 

  24. Lanka B, Jang HJ, Kim TK, Burns PN, Wilson SR (2007) Impact of contrast-enhanced ultrasonography in a tertiary clinical practice. J Ultrasound Med 26(12):1703–1714

    PubMed  Google Scholar 

  25. Loyer EM, Chin H, DuBrow RA, David CL, Eftekhari F, Charnsangavej C (1999) Hepatocellular carcinoma and intrahepatic peripheral cholangiocarcinoma: enhancement patterns with quadruple phase helical CT—a comparative study. Radiology 212(3):866–875

    PubMed  CAS  Google Scholar 

  26. Lee KH, O’Malley ME, Haider MA, Hanbidge A (2004) Triple-phase MDCT of hepatocellular carcinoma. AJR Am J Roentgenol 182(3):643–649

    PubMed  CAS  Google Scholar 

  27. Schima W, Hammerstingl R, Catalano C, Marti-Bonmati L, Rummeny EJ, Montero FT, Dirisamer A, Westermayer B, Bellomi M, Brisbois D, Chevallier P, Dobritz M, Drouillard J, Fraioli F, Jesus Martinez M, Morassut S, Vogl TJ (2006) Quadruple-phase MDCT of the liver in patients with suspected hepatocellular carcinoma: effect of contrast material flow rate. AJR Am J Roentgenol 186(6):1571–1579

    PubMed  Google Scholar 

  28. Kim SK, Lim JH, Lee WJ, Kim SH, Choi D, Lee SJ, Lim HK, Kim H (2002) Detection of hepatocellular carcinoma: comparison of dynamic three-phase computed tomography images and four-phase computed tomography images using multidetector row helical computed tomography. J Comput Assist Tomogr 26(5):691–698

    PubMed  Google Scholar 

  29. Laghi A, Iannaccone R, Rossi P, Carbone I, Ferrari R, Mangiapane F, Nofroni I, Passariello R (2003) Hepatocellular carcinoma: detection with triple-phase multi-detector row helical CT in patients with chronic hepatitis. Radiology 226(2):543–549

    PubMed  Google Scholar 

  30. Murakami T, Kim T, Kawata S, Kanematsu M, Federle MP, Hori M, Okada A, Kumano S, Sugihara E, Tomoda K, Nakamura H (2003) Evaluation of optimal timing of arterial phase imaging for the detection of hypervascular hepatocellular carcinoma by using triple arterial phase imaging with multidetector-row helical computed tomography. Invest Radiol 38(8):497–503

    PubMed  Google Scholar 

  31. Lim JH, Choi D, Kim SH, Lee SJ, Lee WJ, Lim HK, Kim S (2002) Detection of hepatocellular carcinoma: value of adding delayed phase imaging to dual-phase helical CT. AJR Am J Roentgenol 179(1):67–73

    PubMed  Google Scholar 

  32. Sommer CM, Schwarzwaelder CB, Stiller W, Schindera ST, Stampfl U, Bellemann N, Holzschuh M, Schmidt J, Weitz J, Grenacher L, Kauczor HU, Radeleff BA (2011) Iodine removal in intravenous dual-energy CT-cholangiography: is virtual non-enhanced imaging effective to replace true non-enhanced imaging? Eur J Radiol 81(4):692–699

    Google Scholar 

  33. Zhang LJ, Peng J, Wu SY, Wang ZJ, Wu XS, Zhou CS, Ji XM, Lu GM (2010) Liver virtual non-enhanced CT with dual-source, dual-energy CT: a preliminary study. Eur Radiol 20(9):2257–2264

    PubMed  Google Scholar 

  34. Stevens WR, Gulino SP, Batts KP, Stephens DH, Johnson CD (1996) Mosaic pattern of hepatocellular carcinoma: histologic basis for a characteristic CT appearance. J Comput Assist Tomogr 20(3):337–342

    PubMed  CAS  Google Scholar 

  35. Stevens WR, Johnson CD, Stephens DH, Batts KP (1994) CT findings in hepatocellular carcinoma: correlation of tumor characteristics with causative factors, tumor size, and histologic tumor grade. Radiology 191(2):531–537

    PubMed  CAS  Google Scholar 

  36. Hollett MD, Jeffrey RB Jr, Nino-Murcia M, Jorgensen MJ, Harris DP (1995) Dual-phase helical CT of the liver: value of arterial phase scans in the detection of small (< or = 1.5 cm) malignant hepatic neoplasms. AJR Am J Roentgenol 164(4):879–884

    PubMed  CAS  Google Scholar 

  37. Baron RL, Oliver JH 3rd, Dodd GD 3rd, Nalesnik M, Holbert BL, Carr B (1996) Hepatocellular carcinoma: evaluation with biphasic, contrast-enhanced, helical CT. Radiology 199(2):505–511

    PubMed  CAS  Google Scholar 

  38. Oliver JH 3rd, Baron RL, Federle MP, Rockette HE Jr (1996) Detecting hepatocellular carcinoma: value of unenhanced or arterial phase CT imaging or both used in conjunction with conventional portal venous phase contrast-enhanced CT imaging. AJR Am J Roentgenol 167(1):71–77

    PubMed  Google Scholar 

  39. Hwang GJ, Kim MJ, Yoo HS, Lee JT (1997) Nodular hepatocellular carcinomas: detection with arterial-, portal-, and delayed-phase images at spiral CT. Radiology 202(2):383–388

    PubMed  CAS  Google Scholar 

  40. Lee HM, Lu DS, Krasny RM, Busuttil R, Kadell B, Lucas J (1997) Hepatic lesion characterization in cirrhosis: significance of arterial hypervascularity on dual-phase helical CT. AJR Am J Roentgenol 169(1):125–130

    PubMed  CAS  Google Scholar 

  41. Kanematsu M, Oliver JH 3rd, Carr B, Baron RL (1997) Hepatocellular carcinoma: the role of helical biphasic contrast-enhanced CT versus CT during arterial portography. Radiology 205(1):75–80

    PubMed  CAS  Google Scholar 

  42. Miller FH, Butler RS, Hoff FL, Fitzgerald SW, Nemcek AA Jr, Gore RM (1998) Using triphasic helical CT to detect focal hepatic lesions in patients with neoplasms. AJR Am J Roentgenol 171(3):643–649

    PubMed  CAS  Google Scholar 

  43. Catalano OA, Choy G, Zhu A, Hahn PF, Sahani DV (2010) Differentiation of malignant thrombus from bland thrombus of the portal vein in patients with hepatocellular carcinoma: application of diffusion-weighted MR imaging. Radiology 254(1):154–162

    PubMed  Google Scholar 

  44. Hanna RF, Aguirre DA, Kased N, Emery SC, Peterson MR, Sirlin CB (2008) Cirrhosis-associated hepatocellular nodules: correlation of histopathologic and MR imaging features. Radiographics 28(3):747–769

    PubMed  Google Scholar 

  45. Kanematsu M, Semelka RC, Leonardou P, Mastropasqua M, Lee JK (2003) Hepatocellular carcinoma of diffuse type: MR imaging findings and clinical manifestations. J Magn Reson Imaging 18(2):189–195

    PubMed  Google Scholar 

  46. Earls JP, Rofsky NM, DeCorato DR, Krinsky GA, Weinreb JC (1997) Hepatic arterial-phase dynamic gadolinium-enhanced MR imaging: optimization with a test examination and a power injector. Radiology 202(1):268–273

    PubMed  CAS  Google Scholar 

  47. Cruite I, Schroeder M, Merkle EM, Sirlin CB (2010) Gadoxetate disodium-enhanced MRI of the liver: part 2, protocol optimization and lesion appearance in the cirrhotic liver. AJR Am J Roentgenol 195(1):29–41

    PubMed  Google Scholar 

  48. Ringe KI, Husarik DB, Sirlin CB, Merkle EM (2010) Gadoxetate disodium-enhanced MRI of the liver: part 1, protocol optimization and lesion appearance in the noncirrhotic liver. AJR Am J Roentgenol 195(1):13–28

    PubMed  Google Scholar 

  49. Taouli B, Koh DM (2010) Diffusion-weighted MR imaging of the liver. Radiology 254(1):47–66

    PubMed  Google Scholar 

  50. Padhani AR, Liu G, Koh DM, Chenevert TL, Thoeny HC, Takahara T, Dzik-Jurasz A, Ross BD, Van Cauteren M, Collins D, Hammoud DA, Rustin GJ, Taouli B, Choyke PL (2009) Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia 11(2):102–125

    PubMed  CAS  Google Scholar 

  51. Ramalho M, Altun E, Heredia V, Zapparoli M, Semelka R (2007) Liver MR imaging: 1.5 T versus 3 T. Magn Reson Imaging Clin N Am 15(3):321–347

    PubMed  Google Scholar 

  52. Merkle EM, Dale BM, Paulson EK (2006) Abdominal MR imaging at 3 T. Magn Reson Imaging Clin N Am 14(1):17–26

    PubMed  Google Scholar 

  53. Hecht EM, Lee RF, Taouli B, Sodickson DK (2007) Perspectives on body MR imaging at ultrahigh field. Magn Reson Imaging Clin N Am 15(3):449–465

    PubMed  Google Scholar 

  54. Kim SH, Lee J, Kim MJ, Jeon YH, Park Y, Choi D, Lee WJ, Lim HK (2009) Gadoxetic acid-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma. AJR Am J Roentgenol 192(6):1675–1681

    PubMed  Google Scholar 

  55. Kadoya M, Matsui O, Takashima T, Nonomura A (1992) Hepatocellular carcinoma: correlation of MR imaging and histopathologic findings. Radiology 183(3):819–825

    PubMed  CAS  Google Scholar 

  56. Honda H, Kaneko K, Kanazawa Y, Hayashi T, Fukuya T, Matsumata T, Maeda T, Masuda K (1997) MR imaging of hepatocellular carcinomas: effect of Cu and Fe contents on signal intensity. Abdom Imaging 22(1):60–66

    PubMed  CAS  Google Scholar 

  57. Honda H, Onitsuka H, Kanazawa Y, Matsumata T, Hayashi T, Kaneko K, Fukuya T, Tateshi Y, Adachi E, Masuda K (1995) MR imaging of hepatocellular carcinoma. Correlation of metal content and signal intensity. Acta Radiol 36(2):163–167

    PubMed  CAS  Google Scholar 

  58. Earls JP, Theise ND, Weinreb JC, DeCorato DR, Krinsky GA, Rofsky NM, Mizrachi H, Teperman LW (1996) Dysplastic nodules and hepatocellular carcinoma: thin-section MR imaging of explanted cirrhotic livers with pathologic correlation. Radiology 201(1):207–214

    PubMed  CAS  Google Scholar 

  59. Matsui O, Kadoya M, Kameyama T, Yoshikawa J, Arai K, Gabata T, Takashima T, Nakanuma Y, Terada T, Ida M (1989) Adenomatous hyperplastic nodules in the cirrhotic liver: differentiation from hepatocellular carcinoma with MR imaging. Radiology 173(1):123–126

    PubMed  CAS  Google Scholar 

  60. Mitchell DG, Palazzo J, Hann HW, Rifkin MD, Burk DL Jr, Rubin R (1991) Hepatocellular tumors with high signal on T1-weighted MR images: chemical shift MR imaging and histologic correlation. J Comput Assist Tomogr 15(5):762–769

    PubMed  CAS  Google Scholar 

  61. Mitchell DG, Rubin R, Siegelman ES, Burk DL Jr, Rifkin MD (1991) Hepatocellular carcinoma within siderotic regenerative nodules: appearance as a nodule within a nodule on MR images. Radiology 178(1):101–103

    PubMed  CAS  Google Scholar 

  62. Hussain HK, Syed I, Nghiem HV, Johnson TD, Carlos RC, Weadock WJ, Francis IR (2004) T2-weighted MR imaging in the assessment of cirrhotic liver. Radiology 230(3):637–644

    PubMed  Google Scholar 

  63. Hecht EM, Holland AE, Israel GM, Hahn WY, Kim DC, West AB, Babb JS, Taouli B, Lee VS, Krinsky GA (2006) Hepatocellular carcinoma in the cirrhotic liver: gadolinium-enhanced 3D T1-weighted MR imaging as a stand-alone sequence for diagnosis. Radiology 239(2):438–447

    PubMed  Google Scholar 

  64. Sandrasegaran K, Akisik FM, Lin C, Tahir B, Rajan J, Aisen AM (2009) The value of diffusion-weighted imaging in characterizing focal liver masses. Acad Radiol 16(10):1208–1214

    PubMed  Google Scholar 

  65. Miller FH, Hammond N, Siddiqi AJ, Shroff S, Khatri G, Wang Y, Merrick LB, Nikolaidis P (2010) Utility of diffusion-weighted MRI in distinguishing benign and malignant hepatic lesions. J Magn Reson Imaging 32(1):138–147

    PubMed  Google Scholar 

  66. Piana G, Trinquart L, Meskine N, Barrau V, Beers BV, Vilgrain V (2010) New MR imaging criteria with a diffusion-weighted sequence for the diagnosis of hepatocellular carcinoma in chronic liver diseases. J Hepatol 55(1):126–132

    PubMed  Google Scholar 

  67. Oi H, Murakami T, Kim T, Matsushita M, Kishimoto H, Nakamura H (1996) Dynamic MR imaging and early-phase helical CT for detecting small intrahepatic metastases of hepatocellular carcinoma. AJR Am J Roentgenol 166(2):369–374

    PubMed  CAS  Google Scholar 

  68. Kim T, Murakami T, Oi H, Matsushita M, Kishimoto H, Igarashi H, Nakamura H, Okamura J (1995) Detection of hypervascular hepatocellular carcinoma by dynamic MRI and dynamic spiral CT. J Comput Assist Tomogr 19(6):948–954

    PubMed  CAS  Google Scholar 

  69. Yoon SH, Lee JM, So YH, Hong SH, Kim SJ, Han JK, Choi BI (2009) Multiphasic MDCT enhancement pattern of hepatocellular carcinoma smaller than 3 cm in diameter: tumor size and cellular differentiation. AJR Am J Roentgenol 193(6):W482–489

    PubMed  Google Scholar 

  70. Bruix J, Sherman M (2011) Management of hepatocellular carcinoma: an update. Hepatology 53(3):1020–1022

    PubMed  Google Scholar 

  71. Imaeda T, Kanematsu M, Mochizuki R, Goto H, Saji S, Shimokawa K (1994) Extracapsular invasion of small hepatocellular carcinoma: MR and CT findings. J Comput Assist Tomogr 18(5):755–760

    PubMed  CAS  Google Scholar 

  72. Chandarana H, Robinson E, Hajdu CH, Drozhinin L, Babb JS, Taouli B (2011) Microvascular invasion in hepatocellular carcinoma: is it predictable with pretransplant MRI? AJR Am J Roentgenol 196(5):1083–1089

    PubMed  Google Scholar 

  73. Bartolozzi C, Crocetti L, Lencioni R, Cioni D, Della Pina C, Campani D (2007) Biliary and reticuloendothelial impairment in hepatocarcinogenesis: the diagnostic role of tissue-specific MR contrast media. Eur Radiol 17(10):2519–2530

    PubMed  Google Scholar 

  74. Lupescu IG, Capsa RA, Gheorghe L, Herlea V, Georgescu SA (2008) Tissue specific MR contrast media role in the differential diagnosis of cirrhotic liver nodules. J Gastrointestin Liver Dis 17(3):341–346

    PubMed  Google Scholar 

  75. Di Martino M, Marin D, Guerrisi A, Baski M, Galati F, Rossi M, Brozzetti S, Masciangelo R, Passariello R, Catalano C (2010) Intraindividual comparison of gadoxetate disodium-enhanced MR imaging and 64-section multidetector CT in the detection of hepatocellular carcinoma in patients with cirrhosis. Radiology 256(3):806–816

    PubMed  Google Scholar 

  76. Choi SH, Lee JM, Yu NC, Suh KS, Jang JJ, Kim SH, Choi BI (2008) Hepatocellular carcinoma in liver transplantation candidates: detection with gadobenate dimeglumine-enhanced MRI. AJR Am J Roentgenol 191(2):529–536

    PubMed  Google Scholar 

  77. Madhoun MF, Fazili J, Bright BC, Bader T, Roberts DN, Bronze MS (2010) Hepatitis C prevalence in patients with hepatocellular carcinoma without cirrhosis. Am J Med Sci 339(2):169–173. doi:10.1097/MAJ.0b013e3181c4af27

    PubMed  Google Scholar 

  78. Liu S, Chan KW, Wang B, Qiao L (2009) Fibrolamellar hepatocellular carcinoma. Am J Gastroenterol 104(10):2617–2624 quiz 2625

    PubMed  Google Scholar 

  79. Mendizabal M, Reddy KR (2009) Current management of hepatocellular carcinoma. Med Clin North Am 93(4):885–900

    PubMed  CAS  Google Scholar 

  80. Kloeckner R, Otto G, Biesterfeld S, Oberholzer K, Dueber C, Pitton MB (2010) MDCT versus MRI assessment of tumor response after transarterial chemoembolization for the treatment of hepatocellular carcinoma. Cardiovasc Intervent Radiol 33(3):532–540

    PubMed  Google Scholar 

  81. De Santis M, Alborino S, Tartoni PL, Torricelli P, Casolo A, Romagnoli R (1997) Effects of lipiodol retention on MRI signal intensity from hepatocellular carcinoma and surrounding liver treated by chemoembolization. Eur Radiol 7(1):10–16

    PubMed  Google Scholar 

  82. Semelka RC, Worawattanakul S, Mauro MA, Bernard SA, Cance WG (1998) Malignant hepatic tumors: changes on MRI after hepatic arterial chemoembolization—preliminary findings. J Magn Reson Imaging 8(1):48–56

    PubMed  CAS  Google Scholar 

  83. Kim S, Mannelli L, Hajdu CH, Babb JS, Clark TW, Hecht EM, Taouli B (2010) Hepatocellular carcinoma: assessment of response to transarterial chemoembolization with image subtraction. J Magn Reson Imaging 31(2):348–355

    PubMed  Google Scholar 

  84. Mannelli L, Kim S, Hajdu CH, Babb JS, Clark TW, Taouli B (2009) Assessment of tumor necrosis of hepatocellular carcinoma after chemoembolization: diffusion-weighted and contrast-enhanced MRI with histopathologic correlation of the explanted liver. AJR Am J Roentgenol 193(4):1044–1052

    PubMed  Google Scholar 

  85. Kamel IR, Bluemke DA, Ramsey D, Abusedera M, Torbenson M, Eng J, Szarf G, Geschwind JF (2003) Role of diffusion-weighted imaging in estimating tumor necrosis after chemoembolization of hepatocellular carcinoma. AJR Am J Roentgenol 181(3):708–710

    PubMed  Google Scholar 

  86. Kamel IR, Bluemke DA, Eng J, Liapi E, Messersmith W, Reyes DK, Geschwind JF (2006) The role of functional MR imaging in the assessment of tumor response after chemoembolization in patients with hepatocellular carcinoma. J Vasc Interv Radiol 17(3):505–512

    PubMed  Google Scholar 

  87. Solbiati L, Ierace T, Tonolini M, Cova L (2004) Guidance and monitoring of radiofrequency liver tumor ablation with contrast-enhanced ultrasound. Eur J Radiol 51(Supp l):S19–23

    PubMed  Google Scholar 

  88. Goldberg SN, Gazelle GS, Compton CC, Mueller PR, Tanabe KK (2000) Treatment of intrahepatic malignancy with radiofrequency ablation: radiologic-pathologic correlation. Cancer 88(11):2452–2463

    PubMed  CAS  Google Scholar 

  89. Khankan AA, Murakami T, Onishi H, Matsushita M, Iannaccone R, Aoki Y, Tono T, Kim T, Hori M, Osuga K, Passariello R, Nakamura H (2008) Hepatocellular carcinoma treated with radio frequency ablation: an early evaluation with magnetic resonance imaging. J Magn Reson Imaging 27(3):546–551

    PubMed  Google Scholar 

  90. Dromain C, de Baere T, Elias D, Kuoch V, Ducreux M, Boige V, Petrow P, Roche A, Sigal R (2002) Hepatic tumors treated with percutaneous radio-frequency ablation: CT and MR imaging follow-up. Radiology 223(1):255–262

    PubMed  Google Scholar 

  91. Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, de Oliveira AC, Santoro A, Raoul JL, Forner A, Schwartz M, Porta C, Zeuzem S, Bolondi L, Greten TF, Galle PR, Seitz JF, Borbath I, Haussinger D, Giannaris T, Shan M, Moscovici M, Voliotis D, Bruix J (2008) Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 359(4):378–390

    PubMed  CAS  Google Scholar 

  92. Krinsky GA, Theise ND, Rofsky NM, Mizrachi H, Tepperman LW, Weinreb JC (1998) Dysplastic nodules in cirrhotic liver: arterial phase enhancement at CT and MR imaging—a case report. Radiology 209(2):461–464

    PubMed  CAS  Google Scholar 

  93. Krinsky GA, Lee VS, Nguyen MT, Rofsky NM, Theise ND, Morgan GR, Teperman LW, Weinreb JC (2001) Siderotic nodules in the cirrhotic liver at MR imaging with explant correlation: no increased frequency of dysplastic nodules and hepatocellular carcinoma. Radiology 218(1):47–53

    PubMed  CAS  Google Scholar 

  94. Krinsky GA, Lee VS, Nguyen MT, Rofsky NM, Theise ND, Morgan GR, Teperman LW, Weinreb JC (2000) Siderotic nodules at MR imaging: regenerative or dysplastic? J Comput Assist Tomogr 24(5):773–776

    PubMed  CAS  Google Scholar 

  95. Krinsky GA, Israel G (2003) Nondysplastic nodules that are hyperintense on T1-weighted gradient-echo MR imaging: frequency in cirrhotic patients undergoing transplantation. AJR Am J Roentgenol 180(4):1023–1027

    PubMed  Google Scholar 

  96. Golfieri R, Renzulli M, Lucidi V, Corcioni B, Trevisani F, Bolondi L (2011) Contribution of the hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI to dynamic MRI in the detection of hypovascular small (</=2 cm) HCC in cirrhosis. Eur Radiol 21(6):1233–1242

    PubMed  Google Scholar 

  97. Shimizu A, Ito K, Koike S, Fujita T, Shimizu K, Matsunaga N (2003) Cirrhosis or chronic hepatitis: evaluation of small (<or = 2-cm) early-enhancing hepatic lesions with serial contrast-enhanced dynamic MR imaging. Radiology 226(2):550–555

    PubMed  Google Scholar 

  98. Kanematsu M, Kondo H, Semelka RC, Matsuo M, Goshima S, Hoshi H, Moriyama N, Itai Y (2003) Early-enhancing non-neoplastic lesions on gadolinium-enhanced MRI of the liver. Clin Radiol 58(10):778–786

    PubMed  CAS  Google Scholar 

  99. Yu JS, Kim KW, Jeong MG, Lee JT, Yoo HS (2000) Nontumorous hepatic arterial-portal venous shunts: MR imaging findings. Radiology 217(3):750–756

    PubMed  CAS  Google Scholar 

  100. Jeong YY, Mitchell DG, Kamishima T (2002) Small (<20 mm) enhancing hepatic nodules seen on arterial phase MR imaging of the cirrhotic liver: clinical implications. AJR Am J Roentgenol 178(6):1327–1334

    PubMed  Google Scholar 

  101. Holland AE, Hecht EM, Hahn WY, Kim DC, Babb JS, Lee VS, West AB, Krinsky GA (2005) Importance of small (< or = 20-mm) enhancing lesions seen only during the hepatic arterial phase at MR imaging of the cirrhotic liver: evaluation and comparison with whole explanted liver. Radiology 237(3):938–944

    PubMed  Google Scholar 

  102. Brancatelli G, Federle MP, Blachar A, Grazioli L (2001) Hemangioma in the cirrhotic liver: diagnosis and natural history. Radiology 219(1):69–74

    PubMed  CAS  Google Scholar 

  103. Talwalkar JA, Yin M, Fidler JL, Sanderson SO, Kamath PS, Ehman RL (2008) Magnetic resonance imaging of hepatic fibrosis: emerging clinical applications. Hepatology 47(1):332–342

    PubMed  Google Scholar 

  104. Villanueva A, Llovet JM (2011) Targeted therapies for hepatocellular carcinoma. Gastroenterology 140(5):1410–1426

    PubMed  CAS  Google Scholar 

  105. Llovet JM, Bruix J (2008) Molecular targeted therapies in hepatocellular carcinoma. Hepatology 48(4):1312–1327. doi:10.1002/hep.22506

    PubMed  CAS  Google Scholar 

  106. Hoshida Y, Toffanin S, Lachenmayer A, Villanueva A, Minguez B, Llovet JM (2010) Molecular classification and novel targets in hepatocellular carcinoma: recent advancements. Semin Liver Dis 30(1):35–51

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiology, The Mount Sinai Medical Center, One Gustave Levy Place, New York, NY, 10129, USA

    Ankur Parikh & Bachir Taouli

Authors
  1. Ankur Parikh
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bachir Taouli
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Bachir Taouli .

Editor information

Editors and Affiliations

  1. M.D. Anderson Cancer Center, Dept. Surgical Oncology, University of Texas, Holcombe Blvd. 1515, Houston, 77030, Texas, USA

    Jean-Nicolas Vauthey

  2. , Dept. of Surgical Oncology, MD Anderson Cancer Center, Holcombe Boulevard, Unit 444 1515, Houston, 77030, USA

    Antoine Brouquet

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Parikh, A., Taouli, B. (2013). Imaging of Hepatocellular Carcinoma: Current Concepts. In: Vauthey, JN., Brouquet, A. (eds) Multidisciplinary Treatment of Hepatocellular Carcinoma. Recent Results in Cancer Research, vol 190. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-16037-0_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-16037-0_3

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-16036-3

  • Online ISBN: 978-3-642-16037-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation